Giving a type of bacteria to humans in the form of a food supplement appear to be effective in reducing cardio-metabolic risk factors, suggests a new pilot study in overweight or obese people, which found reductions in liver inflammation markers, 2.3 kg average body weight, and cholesterol levels.

Giving a type of bacteria to humans in the form of a food supplement appear to be effective in reducing cardio-metabolic risk factors, suggests a new pilot study in overweight or obese people, which found reductions in liver inflammation markers, 2.3 kg average body weight, and cholesterol levels.: https://ift.tt/2Jm3g5H Read more... https://ift.tt/2XnXTwD